Table 3 Statistical analysis of incidence and mortality
From: Forecasting lung cancer incidence, mortality, and prevalence to year 2030
INCIDENCE | |||
Covariate | HR | 95% C.I. | P value |
Sex | |||
 Male (ref.) | (1) | – | – |
 Females | 0.803 | 0.789; 0.819 | < 0.0001 |
Year (ref.:2006) | 0.995 | 0.992; 0.999 | 0.005 |
AgeGrp | |||
  < 60 (ref.) | (1) | – | – |
 60–69 | 4.499 | 4.374; 4.628 | < 0.0001 |
 70–79 | 8.286 | 8.059; 8.520 | < 0.0001 |
  > 80 | 6.977 | 6.755; 7.207 | < 0.0001 |
MORTALITY | |||
Covariate | HR | 95% C.I. (a) | P value |
Sex | |||
 Male (ref.) | (1) | – | – |
 Females | 0.809 | 0.761; 0.859 | < 0.0001 |
Year (ref.: 2006) | 0.944 | 0.934; 0.954 | < 0.0001 |
AgeGrp | |||
  < 60 | (1) | – | – |
 60–69 | 1.058 | 0.963; 1.162 | 0.242 |
 70–79 | 1.208 | 1.102; 1.323 | < 0.0001 |
  > 80 | 1.756 | 1.606; 1.921 | < 0.0001 |
CCI | |||
 0 (ref.) | (1) | – | – |
 1 | 1.447 | 1.355; 1.501 | < 0.0001 |
 2 | 1.339 | 1.243; 1.435 | < 0.0001 |
  > 2 | 1.857 | 1.735; 1.989 | < 0.0001 |